Home › Retrophin Signs U.S. License Agreement for Syntocinon Nasal Spray (Oxytocin)
 

Keywords :   


Retrophin Signs U.S. License Agreement for Syntocinon Nasal Spray (Oxytocin)

2013-12-19 08:09:31| dairynetwork News Articles

Retrophin, Inc. recently announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon™ Nasal Spray, the intranasal formulation of a synthetic version of the naturally occurring peptide hormone oxytocin, for an upfront payment of $5.0 million plus milestone payments and royalties. Syntocinon™ Nasal Spray was approved in the U.S. in 1960 to assist initial postpartum milk ejection, but was discontinued by Novartis in 1997 for

Tags: agreement license signs spray

Category:Agriculture and Forestry

Latest from this category

All news
28.09BIO completes transition of Thr Pro 80% to 85% Active
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
27.09Washington Corner | September 2024
27.09Dont buy em books about the cattle market
27.09New vaccine technology may offer new solution
27.09U.S. pork producers, veterinarians applaud UN antimicrobial mandate decision
27.09Take time now to prepare swine barns for colder weather
Agriculture and Forestry »
29.09Tropical Depression Twelve Public Advisory Number 1
29.09Summary for Tropical Depression Twelve (AT2/AL122024)
29.09Tropical Depression Twelve Wind Speed Probabilities Number 1
29.09Tropical Storm Joyce Forecast Discussion Number 10
29.09Tropical Depression Twelve Forecast Discussion Number 1
29.09Tropical Depression Twelve Graphics
29.09Tropical Storm Joyce Graphics
29.09Tropical Storm Joyce Wind Speed Probabilities Number 10
More »